(Q43987669)

28 November 2017

title

False-negative testing errors in routine viral marker screening of blood donors. For the Retrovirus Epidemiology Donor Study (English)

1 reference

28 November 2017

1 reference

Busch MP

1

1 reference

28 November 2017

Watanabe KK

2

1 reference

28 November 2017

Smith JW

3

1 reference

28 November 2017

Hermansen SW

4

1 reference

28 November 2017

Thomson RA

5

1 reference

28 November 2017

publication date

1 May 2000

1 reference

28 November 2017

1 reference

28 November 2017

volume

40

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

585-589

1 reference

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

A pattern of 5-1-1 and c100-3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

Comparative evaluation of supplemental hepatitis C virus antibody test systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2000.40050585.X

10.1046/J.1537-2995.2000.40050585.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference